Search - tctmd.com

Displaying 41 - 53 of 53

Sort: Relevancy | Date

News Industry News

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

October 28, 2013

News Industry News

Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System

September 12, 2013

News Industry News

Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold

June 11, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Daily News

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

March 25, 2013

News Daily News

BIOSOLVE-1 Confirma la Mejora en los Stents Bioabsorbibles liberadores de Paclitaxel

March 25, 2013

News Conference News TCT 2012

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

October 24, 2012

News Industry News

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

March 06, 2012

News Industry News

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

December 07, 2011

News Industry News

Abbott to Present New Data for Key Vascular Products at TCT 2011

November 03, 2011

News Industry News

Micell Technologies Announces Presentation of Clinical Data at TCT 2011

November 02, 2011

News Industry News

Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia

September 08, 2011

News Industry News

Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease

January 09, 2011

Advertisement

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System

Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

BIOSOLVE-1 Confirma la Mejora en los Stents Bioabsorbibles liberadores de Paclitaxel

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

Abbott to Present New Data for Key Vascular Products at TCT 2011

Micell Technologies Announces Presentation of Clinical Data at TCT 2011

Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia

Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content